2012
DOI: 10.1016/j.fertnstert.2012.04.026
|View full text |Cite
|
Sign up to set email alerts
|

Paternal and maternal carriage of the annexin A5 M2 haplotype are equal risk factors for recurrent pregnancy loss: a pilot study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

8
63
1
1

Year Published

2015
2015
2019
2019

Publication Types

Select...
7

Relationship

6
1

Authors

Journals

citations
Cited by 46 publications
(72 citation statements)
references
References 37 publications
8
63
1
1
Order By: Relevance
“…This confirms a pilot study that showed that the M2 haplotype confers the same relative risk to carriers of both sexes, based on 30 couples (Rogenhofer et al 2012) and a more recent study based on 109 couples (Tüttelmann et al 2013). Based on the findings from these studies, screening for the M2 haplotype in both partners in RM couples should be considered.…”
Section: Discussionsupporting
confidence: 84%
“…This confirms a pilot study that showed that the M2 haplotype confers the same relative risk to carriers of both sexes, based on 30 couples (Rogenhofer et al 2012) and a more recent study based on 109 couples (Tüttelmann et al 2013). Based on the findings from these studies, screening for the M2 haplotype in both partners in RM couples should be considered.…”
Section: Discussionsupporting
confidence: 84%
“…The odds ratios of M2-carrying RPL patients from this study, 1.4 with population controls and 1.9 with parous women, are similar to these of European RPL cohorts, 1.5 to 2.5 with population controls and 3 to 5 with parous controls [5,21,22], as well as to the reported odds ratio of 2.4 with parous women from the Japanese study [20]. Attributable predisposition of male M2 carriers in Malay RPL couples is thus in general agreement with these previous studies, supporting the proposed pathophysiological expression of M2/ANXA5 in impediment of embryonic anticoagulation.…”
Section: Discussionsupporting
confidence: 79%
“…Male partners of 146 of these women agreed to participate in the study. RPL subjects were pre-screened for potential causes of their repeated pregnancy loss as described previously [21,24]. Uterine anomalies and endocrine dysfunctions (polycystic ovary syndrome according to the Rotterdam criteria [25] and thyroidal dysfunctions, if anamnestic) were not included.…”
Section: Study Populationsmentioning
confidence: 99%
See 1 more Smart Citation
“…The haplotype is present in about 15% of European populations studied so far Tüttelmann et al, 2013), in 11% of the Japanese (Miyamura et al, 2011), and confers about a two-fold elevated RSA risk in relevant patient groups. Available evidence links carriage of M2/ANXA5 with reduced expression of ANXA5 in chorionic placenta Markoff et al, 2010), and associated similar risks of male carriers in couples who have experienced RSA point to a possibly impeded embryonic anticoagulant function (Rogenhofer et al, 2012;Tüttelmann et al, 2013).…”
Section: Introductionmentioning
confidence: 99%